20 years of effort, only to create the brand ENTaccess. Recently, ENT Medical Instrument（Liaoning）Co., Ltd. was officially established in Dalian Free Trade Zone! The company is mainly engaged in the research and development, production and sales of otolaryngology medical equipment, and is a high-tech medical equipment technology enterprise with high starting point.
ENT diseases are common in daily life, such as allergic rhinitis, vocal cord polyps, tinnitus, snoring and so on. It is understood that there are about 20 million newly increased patients with ENT diseases in China every year. According to the research of Evaluate, a medical market information and data consulting company, the global market scale of ENT treatment in 2016 is about 8 billion US dollars, and the CAGR (compound annual growth rate) is 5.5% from 2016 to 2022.
With the increasing quality of life, rhinoplasty is more popular than ever. According to the report of the American Society of Plastic Surgeons, more than 225000 people underwent nasal plastic surgery in 2019, with an average annual growth rate of 6% - 8%.
Mr. Luan Yubao, the chairman of the company, said: "In the future, ENT Medical Instrument（Liaoning）Co., Ltd. will provide products that are easy to operate and with overall service as much as possible. Meanwhile we guarantee the product quality, reduce Logistics Costs, and provide convenience for doctors' preparation before diagnosis and treatment, as well as their manipulation in the process of diagnosis and treatment!”
Another senior executive of the company, Mr. Zhang Deyu, said: "At present, medical investment is still hot, and the segment market of ENT medical instrument is broad and the market hasn't been fully developed. It is expected that more and more enterprises will enter this field in the future. We will work steadily, realize product transformation and landing quickly, and strive to win more people's favor and recognition with strong perseverance and long-term vision."